Search Login Register

reteplase Summary

Description: mutant form of tissue plasminogen activator used in treatment of myocardial infarct

Also Known As: Biovail brand of reteplase; Centocor brand of reteplase; Rapilysin; Retavase; Roche brand of reteplase Show All >>

Networked: 148 relevant articles (15 outcomes, 42 trials/studies) for this Drug

Key Diseases for which reteplase is Relevant

  1. Stroke (Strokes) : 5 outcomes 3 studies in 29 results
  2. Myocardial Infarction : 3 outcomes 34 studies in 74 results
  3. Arterial Occlusive Diseases (Arterial Occlusive Disease) : 3 outcomes 2 studies in 4 results
  4. Neoplasms (Cancer) : 2 outcomes in 2 results
  5. Hemorrhage : 1 outcome 4 studies in 17 results
Show All >>

Drugs Related to reteplase

  1. abciximab (ReoPro)
  2. Tissue Plasminogen Activator (Alteplase)
  3. Streptokinase
  4. Glycoproteins (Glycoprotein)
  5. glucuronyl glucosamine glycan sulfate (Vessel)
  6. Plasminogen Activators (Plasminogen Activator)
  7. Platelet Membrane Glycoprotein IIb
  8. Fibrinolytic Agents (Antithrombotic Agents)
  9. tenecteplase
  10. Fibrin
Show All >>

Therapies Related to reteplase

  1. Catheters
  2. Angioplasty (Angioplasty, Transluminal)
  3. Stents
  4. Thrombolytic Therapy
  5. Limb Salvage
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.